180 related articles for article (PubMed ID: 26521826)
1. Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids.
Sakurada T; Kakiuchi S; Tajima S; Horinouchi Y; Konaka K; Okada N; Nishisako H; Nakamura T; Teraoka K; Kawazoe K; Yanagawa H; Nishioka Y; Ishizawa K
Biol Pharm Bull; 2015; 38(11):1752-6. PubMed ID: 26521826
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study.
Sakurada T; Nokihara H; Koga T; Zamami Y; Goda M; Yagi K; Hamano H; Aizawa F; Ogino H; Sato S; Kirino Y; Goto H; Nishioka Y; Ishizawa K
Oncologist; 2022 Jul; 27(7):e554-e560. PubMed ID: 35325241
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of Risk Factors for Side Effects and the Establishment of Supportive Therapy during Cancer Chemotherapy].
Sakurada T
Yakugaku Zasshi; 2018; 138(11):1363-1370. PubMed ID: 30381644
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cutaneous reactions with pemetrexed: Comparison of patients who received three days of oral dexamethasone twice daily to patients who did not.
Clark SK; Anselmo LM
J Oncol Pharm Pract; 2019 Oct; 25(7):1645-1650. PubMed ID: 30319062
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of steroids for the rash side effect of pemetrexed].
Ishikawa H; Onishi T; Kobayashi R; Ohashi Y; Suzuki K; Yamamoto N; Shino M
Gan To Kagaku Ryoho; 2013 Jan; 40(1):75-8. PubMed ID: 23306922
[TBL] [Abstract][Full Text] [Related]
6. Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions.
Elsoueidi R; Lander MJ; Richa EM; Adane ED
J Oncol Pharm Pract; 2016 Apr; 22(2):271-4. PubMed ID: 25908647
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
8. FDA drug approval summaries: pemetrexed (Alimta).
Hazarika M; White RM; Johnson JR; Pazdur R
Oncologist; 2004; 9(5):482-8. PubMed ID: 15477632
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
Shukuya T; Ko R; Mori K; Kato M; Yagishita S; Kanemaru R; Honma Y; Shibayama R; Koyama R; Shimada N; Takahashi K
Cancer Chemother Pharmacol; 2015 Oct; 76(4):771-6. PubMed ID: 26259641
[TBL] [Abstract][Full Text] [Related]
10. Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.
Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A
Lung Cancer; 2015 Jun; 88(3):319-24. PubMed ID: 25870156
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer.
Ikesue H; Watanabe H; Hirano M; Chikamori A; Suetsugu K; Ryokai Y; Egashira N; Yamada T; Ikeda M; Iwama E; Harada T; Takayama K; Nakanishi Y; Masuda S
Biol Pharm Bull; 2015; 38(8):1192-8. PubMed ID: 26235582
[TBL] [Abstract][Full Text] [Related]
12. Comparison between two premedication regimens of dexamethasone before a pemetrexed-based chemotherapy: A single-center experience study.
Groleau A; Côté J
J Oncol Pharm Pract; 2020 Apr; 26(3):612-618. PubMed ID: 31370748
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
Lal R; Hillerdal GN; Shah RN; Crosse B; Thompson J; Nicolson M; Vikström A; Potter VA; Visseren-Grul C; Lorenzo M; D'yachkova Y; Bourayou N; Summers YJ
Lung Cancer; 2015 Aug; 89(2):154-60. PubMed ID: 26101013
[TBL] [Abstract][Full Text] [Related]
14. Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study.
Sun Y; Wu YL; Zhou CC; Zhang L; Zhang L; Liu XY; Yu SY; Jiang GL; Li K; Qin SK; Ma SL; Han L; Quinlivan M; Orlando M; Zhang XQ
Lung Cancer; 2013 Feb; 79(2):143-50. PubMed ID: 23182660
[TBL] [Abstract][Full Text] [Related]
15. [Safety of pemetrexed according to the duration of vitamin B12 and folic acid supplementation prior to the first dose of pemetrexed].
Tsuda Y; Kitamura A; Nishimura N; Yagi N; Takayama S; Okafuji K; Tomishima Y; Jinta T; Koyama K; Ohde S; Gotoh K; Chohnabayashi N
Gan To Kagaku Ryoho; 2015 Apr; 42(4):471-5. PubMed ID: 25963695
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid rotation to alleviate dexamethasone-induced hiccup: a case series at a single institution.
Kang JH; Hui D; Kim MJ; Kim HG; Kang MH; Lee GW; Bruera E
J Pain Symptom Manage; 2012 Mar; 43(3):625-30. PubMed ID: 21924583
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.
Takagi Y; Hosomi Y; Nagamata M; Watanabe K; Takahashi S; Nakahara Y; Yomota M; Sunami K; Okuma Y; Shimokawa T; Okamura T
Cancer Chemother Pharmacol; 2016 Mar; 77(3):559-64. PubMed ID: 26821156
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed versus docetaxel in second line non-small-cell lung cancer: results and subsets analyses of a multi-center, randomized, exploratory trial in Chinese patients.
Li R; Sun L; Wang J; Qian J; Wang Z; Jiao X
Pulm Pharmacol Ther; 2012 Oct; 25(5):364-70. PubMed ID: 22766314
[TBL] [Abstract][Full Text] [Related]
19. The role of corticosteroids in the treatment of croup.
Rittichier KK
Treat Respir Med; 2004; 3(3):139-45. PubMed ID: 15219173
[TBL] [Abstract][Full Text] [Related]
20. Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.
Kanai M; Matsumoto S; Nishimura T; Matsumura Y; Hatano E; Mori A; Masui T; Kawaguchi Y; Nakamura E; Tada S; Kitano T; Ishiguro H; Yanagihara K; Chiba T
Ann Oncol; 2010 Jan; 21(1):189-90. PubMed ID: 19889615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
